Safety and Immunogenicity of Omicron Variant-Matched Vaccine Booster in Adults

NCT05383560 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

179

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID-19 Pandemic
Immunogenicity
SARS CoV 2 Infection
COVID-19

Interventions

BIOLOGICAL: mRNA-1273.214 Vaccine
BIOLOGICAL: MRNA-1273 Vaccine
BIOLOGICAL: Placebo
BIOLOGICAL: MRNA-1273.222 Vaccine

Sponsor

Sheba Medical Center

Collaborators

[object Object]